← FDA Drug Approvals (Drugs@FDA)

KIMMTRAK

BLA · Biologics License Application · Sponsor: IMMUNOCORE LTD · Approved 2022-01-25

Drug application

FDA Application #

BLA761228

Application type

Biologics License Application

Brand name

KIMMTRAK

Generic name

TEBENTAFUSP

Active ingredients

TEBENTAFUSP-TEBN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

IMMUNOCORE LTD

Manufacturer

Immunocore Commercial LLC

First approval

2022-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown